Artrya Future Growth
Future criteria checks 5/6
Artrya is forecast to grow earnings and revenue by 54.1% and 49.4% per annum respectively. EPS is expected to grow by 69.7% per annum. Return on equity is forecast to be 4.9% in 3 years.
Key information
54.1%
Earnings growth rate
69.65%
EPS growth rate
| Healthcare Services earnings growth | 4.1% |
| Revenue growth rate | 49.4% |
| Future return on equity | 4.94% |
| Analyst coverage | Low |
| Last updated | 26 May 2026 |
Recent future growth updates
Recent updates
US CCTA Adoption And New Reimbursement Will Drive Long Term Cardiac AI Potential
Catalysts About Artrya Artrya develops AI-powered cardiac imaging software that helps clinicians assess coronary anatomy, plaque and blood flow from CCTA scans. What are the underlying business or industry changes driving this perspective?We're Hopeful That Artrya (ASX:AYA) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, Artrya ( ASX:AYA...We Think Artrya (ASX:AYA) Needs To Drive Business Growth Carefully
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...Here's Why We're Not Too Worried About Artrya's (ASX:AYA) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...We're Not Very Worried About Artrya's (ASX:AYA) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2029 | 79 | 37 | 37 | 29 | 2 |
| 6/30/2028 | 34 | -1 | -2 | 0 | 3 |
| 6/30/2027 | 13 | -13 | -8 | -10 | 3 |
| 6/30/2026 | 4 | -20 | -17 | -17 | 3 |
| 12/31/2025 | 0 | -20 | -21 | -21 | N/A |
| 9/30/2025 | 0 | -18 | -18 | -18 | N/A |
| 6/30/2025 | 0 | -16 | -15 | -14 | N/A |
| 3/31/2025 | 0 | -15 | -13 | -13 | N/A |
| 12/31/2024 | 0 | -15 | -12 | -12 | N/A |
| 9/30/2024 | 0 | -14 | -14 | -14 | N/A |
| 6/30/2024 | N/A | -14 | -15 | -15 | N/A |
| 3/31/2024 | N/A | -13 | -16 | -14 | N/A |
| 12/31/2023 | N/A | -12 | -16 | -12 | N/A |
| 9/30/2023 | N/A | -11 | -16 | -12 | N/A |
| 6/30/2023 | N/A | -11 | -17 | -11 | N/A |
| 3/31/2023 | N/A | -14 | -17 | -11 | N/A |
| 12/31/2022 | N/A | -17 | -18 | -11 | N/A |
| 9/30/2022 | N/A | -17 | -17 | -10 | N/A |
| 6/30/2022 | N/A | -17 | -16 | -10 | N/A |
| 3/31/2022 | N/A | -13 | -13 | -8 | N/A |
| 12/31/2021 | N/A | -9 | -10 | -6 | N/A |
| 9/30/2021 | N/A | -6 | -7 | -4 | N/A |
| 6/30/2021 | N/A | -4 | -4 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AYA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.6%).
Earnings vs Market: AYA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AYA is expected to become profitable in the next 3 years.
Revenue vs Market: AYA's revenue (49.4% per year) is forecast to grow faster than the Australian market (6% per year).
High Growth Revenue: AYA's revenue (49.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AYA's Return on Equity is forecast to be low in 3 years time (4.9%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/01 17:12 |
| End of Day Share Price | 2026/07/01 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Artrya Limited is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Melissa Benson | Barrenjoey Markets Pty Limited |
| Martyn Jacobs | Bell Potter |
| Andrew Wilkinson | Venn Brown Pty Ltd |